|
|
2型糖尿病与结直肠腺瘤关系研究进展
|
Abstract:
多数结直肠癌(Colorectal Cancer, CRC)是从结直肠腺瘤(Colorectal Adenomas, CRA)演变而来的。目前主要通过早期发现和切除结直肠腺瘤来预防结直肠癌的发生。2型糖尿病(Type 2 Diabetes Mellitus, T2DM)作为一种代谢性疾病，与多种癌症密切相关，包括结直肠癌。近年来，有研究显示2型糖尿病也是结直肠腺瘤的独立危险因素，其中潜在机制尚不明确。本文主要从2型糖尿病与结直肠腺瘤相关性、糖尿病人群中影响结直肠腺瘤发生的影响因素、两者可能的潜在机制进行综述，以提高对临床早期筛查高风险人群的重视。
The majority of colorectal cancer cases are attributed to the presence of colorectal adenomas. Currently, the primary approach for preventing colorectal adenomas is through early detection and removal. Type 2 diabetes mellitus, as a metabolic disorder, exhibits a robust association with various cancers, including colorectal cancer. Recent studies consistently demonstrate that type 2 diabetes mellitus independently increases the risk of developing colorectal adenomas; however, the precise underlying mechanisms remain incompletely elucidated. This paper aims to explore the correlation between type 2 diabetes mellitus and colorectal adenomas, identify factors influencing their development in individuals with diabetes, and shed light on potential underlying mechanisms. The findings underscore the significance of early clinical screening among high-risk groups.
| [1] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 国际内分泌代谢杂志, 2021, 41(5): 482-548. |
| [2] | Sun, H., Saeedi, P., Karuranga, S., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article ID: 109119. https://doi.org/10.1016/j.diabres.2021.109119 |
| [3] | Brown, J.C., Zhang, S., Ou, F.S., et al. (2020) Diabetes and Clinical Outcome in Patients with Metastatic Colorectal Cancer: CALGB 80405 (Alliance). JNCI Cancer Spectrum, 4, pkz078. https://doi.org/10.1093/jncics/pkz078 |
| [4] | Dekker, E., Tanis, P.J., Vleugels, J.L.A., et al. (2019) Colorectal Cancer. Lancet, 394, 1467-1480. https://doi.org/10.1016/S0140-6736(19)32319-0 |
| [5] | Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660 |
| [6] | 练佳韦, 刘颖春, 余红平. 结直肠癌的全球流行情况、危险因素及归因疾病负担研究进展[J]. 中国癌症防治杂志, 2024, 16(1): 1-9. |
| [7] | Haumaier, F., Sterlacci, W. and Vieth, M. (2017) Histological and Molecular Classification of Gastrointestinal Polyps. Best Practice & Research Clinical Gastroenterology, 31, 369-379. https://doi.org/10.1016/j.bpg.2017.06.005 |
| [8] | Nagtegaal, I.D., Odze, R.D., Klimstra, D., et al. (2020) The 2019 WHO Classification of Tumours of the Digestive System. Histopathology, 76, 182-188. https://doi.org/10.1111/his.13975 |
| [9] | Nguyen, L.H., Goel, A. and Chung, D.C. (2020) Pathways of Colorectal Carcinogenesis. Gastroenterology, 158, 291-302. https://doi.org/10.1053/j.gastro.2019.08.059 |
| [10] | Luo, S., Li, J.Y., Zhao, L.N., et al. (2016) Diabetes Mellitus Increases the Risk of Colorectal Neoplasia: An Updated Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology, 40, 110-123. https://doi.org/10.1016/j.clinre.2015.05.021 |
| [11] | Wang, H., Wang, P., Liu, X., et al. (2019) Factors Predicting the Colorectal Adenoma Detection Rate in Colonoscopic Screening of a Chinese Population: A Prospective Study. Medicine, 98, e15103. https://doi.org/10.1097/MD.0000000000015103 |
| [12] | Joseph, D.F., Li, E., Stanley, Iii, S.L., et al. (2021) Impact of Type 2 Diabetes on Adenoma Detection in Screening Colonoscopies Performed in Disparate Populations. World Journal of Clinical Cases, 9, 2433-2445. https://doi.org/10.12998/wjcc.v9.i11.2433 |
| [13] | Ottaviano, L.F., Li, X., Murray, M., et al. (2020) Type 2 Diabetes Impacts Colorectal Adenoma Detection in Screening Colonoscopy. Scientific Reports, 10, Article No. 7793. https://doi.org/10.1038/s41598-020-64344-2 |
| [14] | Soltani, G., Poursheikhani, A., Yassi, M., et al. (2019) Obesity, Diabetes and the Risk of Colorectal Adenoma and Cancer. BMC Endocrine Disorders, 19, Article No. 113. https://doi.org/10.1186/s12902-019-0444-6 |
| [15] | Vu, H.T., Ufere, N., Yan, Y., et al. (2014) Diabetes Mellitus Increases Risk for Colorectal Adenomas in Younger Patients. World Journal of Gastroenterology, 20, 6946-6952. https://doi.org/10.3748/wjg.v20.i22.6946 |
| [16] | Bouwens, M.W., Winkens, B., Rondagh, E.J., et al. (2013) Simple Clinical Risk Score Identifies Patients with Serrated Polyps in Routine Practice. Cancer Prevention Research, 6, 855-863. https://doi.org/10.1158/1940-6207.CAPR-13-0022 |
| [17] | Lui, R.N., Kyaw, M.H., Lam, T.Y.T., et al. (2021) Prevalence and Risk Factors for Sessile Serrated Lesions in an Average Risk Colorectal Cancer Screening Population. Journal of Gastroenterology and Hepatology, 36, 1656-1662. https://doi.org/10.1111/jgh.15368 |
| [18] | Zhang, R., Ni, Y., Guo, C.L., et al. (2023) Risk Factors for Sessile Serrated Lesions among Chinese Patients Undergoing Colonoscopy. Journal of Gastroenterology and Hepatology, 38, 1468-1473. https://doi.org/10.1111/jgh.16200 |
| [19] | Anderson, J.C., Rangasamy, P., Rustagi, T., et al. (2011) Risk Factors for Sessile Serrated Adenomas. Journal of Clinical Gastroenterology, 45, 694-699. https://doi.org/10.1097/MCG.0b013e318207f3cf |
| [20] | Cheng, L.Z., Pu, T., Rana, K., Singh, G., et al. (2020) Different Factors Are Associated with Conventional Adenoma and Serrated Colorectal Neoplasia. Nagoya Journal of Medical Science, 82, 335-343. |
| [21] | 于景霞, 钟继红, 郑华君, 等. 2型糖尿病患者结直肠腺瘤临床病理特征和进展期腺瘤危险因素分析[J]. 胃肠病学, 2021, 26(4): 193-197. |
| [22] | Yu, F., Guo, Y., Wang, H., et al. (2016) Type 2 Diabetes Mellitus and Risk of Colorectal Adenoma: A Meta-Analysis of Observational Studies. BMC Cancer, 16, Article No. 642. https://doi.org/10.1186/s12885-016-2685-3 |
| [23] | Breau, G. and Ellis, U. (2020) Risk Factors Associated with Young-Onset Colorectal Adenomas and Cancer: A Systematic Review and Meta-Analysis of Observational Research. Cancer Control, 27, 1-11. https://doi.org/10.1177/1073274820976670 |
| [24] | Rhee, S.Y. and Woo, J.T. (2011) The Prediabetic Period: Review of Clinical Aspects. Diabetes & Metabolism Journal, 35, 107-116. https://doi.org/10.4093/dmj.2011.35.2.107 |
| [25] | Cha, J.M., Lee, J.I., Joo, K.R., et al. (2013) Prediabetes Is Associated with a High-Risk Colorectal Adenoma. Digestive Diseases and Sciences, 58, 2061-2067. https://doi.org/10.1007/s10620-013-2591-3 |
| [26] | Huang, X., Fan, Y., Zhang, H., et al. (2015) Association between Serum HbA1c Levels and Adenomatous Polyps in Patients with the Type 2 Diabetes Mellitus. Minerva Endocrinology, 40, 163-167. |
| [27] | Siddiqui, A.A., Maddur, H., Naik, S., et al. (2008) The Association of Elevated HbA1c on the Behavior of Adenomatous Polyps in Patients with Type-II Diabetes Mellitus. Digestive Diseases and Sciences, 53, 1042-1047. https://doi.org/10.1007/s10620-007-9970-6 |
| [28] | Shin, H.S. and Cho, Y.J. (2022) Insulin Levels Are Associated with Risk of Colon Adenoma and Not Nonadenomatous Polyps: A Retrospective, Hospital-Based Study. Medicine, 101, e30200. https://doi.org/10.1097/MD.0000000000030200 |
| [29] | Kim, E.H., Kim, H.K., Bae, S.J., et al. (2014) Fasting Serum Insulin Levels and Insulin Resistance Are Associated with Colorectal Adenoma in Koreans. Journal of Diabetes Investigation, 5, 297-304. https://doi.org/10.1111/jdi.12178 |
| [30] | Nagel, J.M., Staffa, J., Renner-Müller, I., et al. (2010) Insulin Glargine and NPH Insulin Increase to a Similar Degree Epithelial Cell Proliferation and Aberrant Crypt Foci Formation in Colons of Diabetic Mice. Hormones and Cancer, 1, 320-330. https://doi.org/10.1007/s12672-010-0020-z |
| [31] | Eddi, R., Karki, A., Shah, A., et al. (2012) Association of Type 2 Diabetes and Colon Adenomas. Journal of Gastrointestinal Cancer, 43, 87-92. https://doi.org/10.1007/s12029-011-9316-7 |
| [32] | Kanadiya, M.K., Gohel, T.D., Sanaka, M.R., et al. (2013) Relationship between Type-2 Diabetes and Use of Metformin with Risk of Colorectal Adenoma in an American Population Receiving Colonoscopy. Journal of Diabetes and its Complications, 27, 463-466. https://doi.org/10.1016/j.jdiacomp.2013.04.010 |
| [33] | Hosono, K., Endo, H., Takahashi, H., et al. (2010) Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-Term Clinical Trial. Cancer Prevention Research, 3, 1077-1083. https://doi.org/10.1158/1940-6207.CAPR-10-0186 |
| [34] | Ng, C.W., Jiang, A.A., Toh, E.M, S., et al. (2020) Metformin and Colorectal Cancer: A Systematic Review, Meta-Analysis and Meta-Regression. International Journal of Colorectal Disease, 35, 1501-1512. https://doi.org/10.1007/s00384-020-03676-x |
| [35] | 吕红, 宋晓华. 不同降糖方案对2型糖尿病合并结直肠腺瘤患者行内镜下腺瘤切除术后腺瘤复发的影响研究[J]. 中国全科医学, 2018, 21(20): 2432-2436. |
| [36] | Jung, Y.S., Park, C.H., Eun, C.S., et al. (2017) Metformin Use and the Risk of Colorectal Adenoma: A Systematic Review and Meta-Analysis. Journal of Gastroenterology and Hepatology, 32, 957-965. https://doi.org/10.1111/jgh.13639 |
| [37] | Du, L., Wang, M., Kang, Y., et al. (2017) Prognostic Role of Metformin Intake in Diabetic Patients with Colorectal Cancer: An Updated Qualitative Evidence of Cohort Studies. Oncotarget, 8, 26448-26459. https://doi.org/10.18632/oncotarget.14688 |
| [38] | Liu, F., Yan, L., Wang, Z., et al. (2017) Metformin Therapy and Risk of Colorectal Adenomas and Colorectal Cancer in Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis. Oncotarget, 8, 16017-16026. https://doi.org/10.18632/oncotarget.13762 |
| [39] | Deng, M., Lei, S., Huang, D., et al. (2020) Suppressive Effects of Metformin on Colorectal Adenoma Incidence and Malignant Progression. Pathology: Research and Practice, 216, Article ID: 152775. https://doi.org/10.1016/j.prp.2019.152775 |
| [40] | Kountouras, J., Polyzos, S.A., Doulberis, M., et al. (2018) Potential Impact of Helicobacter pylori-Related Metabolic Syndrome on Upper and Lower Gastrointestinal Tract Oncogenesis. Metabolism, 87, 18-24. https://doi.org/10.1016/j.metabol.2018.06.008 |
| [41] | Hu, K.C., Wu, M.S., Chu, C.H., et al. (2017) Synergistic Effect of Hyperglycemia and Helicobacter pylori Infection Status on Colorectal Adenoma Risk. The Journal of Clinical Endocrinology & Metabolism, 102, 2744-2750. https://doi.org/10.1210/jc.2017-00257 |
| [42] | Ko, H.J., Lin, Y.C., Chen, C.C., et al. (2021) Helicobacter Pylori Infection and Increased Diabetes Prevalence Were the Risks of Colorectal Adenoma for Adults: A Systematic Review and Meta-Analysis (PRISMA-Compliant Article). Medicine, 100, e28156. https://doi.org/10.1097/MD.0000000000028156 |
| [43] | Lu, L., Koo, S., Mcpherson, S., et al. (2022) Systematic Review and Meta-Analysis: Associations between Metabolic Syndrome and Colorectal Neoplasia Outcomes. Colorectal Disease, 24, 681-694. https://doi.org/10.1111/codi.16092 |
| [44] | Trabulo, D., Ribeiro, S., Martins, C., et al. (2015) Metabolic Syndrome and Colorectal Neoplasms: An Ominous Association. World Journal of Gastroenterology, 21, 5320-5327. https://doi.org/10.3748/wjg.v21.i17.5320 |
| [45] | Tsugane, S. and Inoue, M. (2010) Insulin Resistance and Cancer: Epidemiological Evidence. Cancer Science, 101, 1073-1079. https://doi.org/10.1111/j.1349-7006.2010.01521.x |
| [46] | Inoue, M. and Tsugane, S. (2012) Insulin Resistance and Cancer: Epidemiological Evidence. Endocrine-Related Cancer, 19, F1-F8. https://doi.org/10.1530/ERC-12-0142 |
| [47] | Bowers, L.W., Rossi, E.L., O’flanagan, C.H., et al. (2015) The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Frontiers in Endocrinology, 6, Article 77. https://doi.org/10.3389/fendo.2015.00077 |
| [48] | Giouleme, O., Diamantidis, M.D. and Katsaros, M.G. (2011) Is Diabetes a Causal Agent for Colorectal Cancer? Pathophysiological and Molecular Mechanisms. World Journal of Gastroenterology, 17, 444-448. https://doi.org/10.3748/wjg.v17.i4.444 |
| [49] | Li, J.Y., Yu, T., Xia, Z.S., et al. (2014) Enhanced Proliferation in Colorectal Epithelium of Patients with Type 2 Diabetes Correlates with β-Catenin Accumulation. Journal of Diabetes and its Complications, 28, 689-697. https://doi.org/10.1016/j.jdiacomp.2014.05.001 |
| [50] | Flood, A., Mai, V., Pfeiffer, R., et al. (2007) Elevated Serum Concentrations of Insulin and Glucose Increase Risk of Recurrent Colorectal Adenomas. Gastroenterology, 133, 1423-1429. https://doi.org/10.1053/j.gastro.2007.08.040 |
| [51] | Itoh, H., Kaneko, H., Okada, A., et al. (2021) Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological Database. The Journal of Clinical Endocrinology & Metabolism, 106, e4448-e4458. https://doi.org/10.1210/clinem/dgab466 |
| [52] | Lega, I.C. and Lipscombe, L.L. (2020) Review: Diabetes, Obesity, and Cancer-Pathophysiology and Clinical Implications. Endocrine Reviews, 41, 33-52. https://doi.org/10.1210/endrev/bnz014 |
| [53] | Chocarro-Calvo, A., García-Martínez, J.M., Ardila-González, S., et al. (2013) Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer. Molecular Cell, 49, 474-486. https://doi.org/10.1016/j.molcel.2012.11.022 |
| [54] | Lunt, S.Y. and Vander Heiden, M.G. (2011) Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation. Annual Review of Cell and Developmental Biology, 27, 441-464. https://doi.org/10.1146/annurev-cellbio-092910-154237 |
| [55] | Azizian-Farsani, F., Abedpoor, N., Hasan Sheikhha, M., et al. (2020) Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development. Frontiers in Oncology, 10, Article 552283. https://doi.org/10.3389/fonc.2020.552283 |
| [56] | Jiao, L., Chen, L., Alsarraj, A., et al. (2012) Plasma Soluble Receptor for Advanced Glycation End-Products and Risk of Colorectal Adenoma. International Journal of Molecular Epidemiology and Genetics, 3, 294-304. |
| [57] | Nie, C., Li, Y., Qian, H., et al. (2022) Advanced Glycation End Products in Food and Their Effects on Intestinal Tract. Critical Reviews in Food Science and Nutrition, 62, 3103-3115. https://doi.org/10.1080/10408398.2020.1863904 |
| [58] | Umar, M.I., Hassan, W., Murtaza, G., et al. (2021) The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis. Pathology and Oncology Research, 27, Article ID: 1609828. https://doi.org/10.3389/pore.2021.1609828 |
| [59] | Joshi, R.K. and Lee, S.A. (2014) Obesity Related Adipokines and Colorectal Cancer: A Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention, 15, 397-405. https://doi.org/10.7314/APJCP.2014.15.1.397 |
| [60] | Jaffe, T. and Schwartz, B. (2008) Leptin Promotes Motility and Invasiveness in Human Colon Cancer Cells by Activating Multiple Signal-Transduction Pathways. International Journal of Cancer, 123, 2543-2556. https://doi.org/10.1002/ijc.23821 |
| [61] | Deng, L., Zhao, X., Chen, M., et al. (2020) Plasma Adiponectin, Visfatin, Leptin, and Resistin Levels and the Onset of Colonic Polyps in Patients with Prediabetes. BMC Endocrine Disorders, 20, Article No. 63. https://doi.org/10.1186/s12902-020-0540-7 |
| [62] | Ahmadi, A., Mobasheri, M., Hashemi-Nazari, S.S., et al. (2014) Prevalence of Hypertension and Type 2 Diabetes Mellitus in Patients with Colorectal Cancer and Their Median Survival Time: A Cohort Study. Journal of Research in Medical Sciences, 19, 850-854. |
